Advertisement
U.S. markets close in 5 hours 13 minutes

Vertex Pharmaceuticals Incorporated (VRTX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
420.58+3.26 (+0.78%)
As of 10:46AM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Triple Moving Average Crossover

Triple Moving Average Crossover

Previous Close417.32
Open419.48
Bid420.03 x 100
Ask420.95 x 100
Day's Range415.06 - 420.67
52 Week Range310.90 - 448.40
Volume170,222
Avg. Volume1,315,203
Market Cap108.639B
Beta (5Y Monthly)0.35
PE Ratio (TTM)30.26
EPS (TTM)13.90
Earnings DateApr 29, 2024 - May 03, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est464.98
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Undervalued
62% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for VRTX

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Vertex Pharmaceuticals Incorpor
    Analyst Report: Vertex Pharmaceuticals, Inc.Vertex Pharmaceuticals develops therapies to address cystic fibrosis and other diseases. The company was founded in 1989 in Cambridge, Massachusetts and has 4,800 employees. It has research programs and facilities in the U.S., the UK, and Canada. The shares are a component of the S&P 500.
    Rating
    Fair Value
    Economic Moat
    last monthArgus Research
View more